Citations 0
Editor's Correspondence
March 8, 2010

Metrics for Evaluating the Utility of Patient-Centered Decision Tools—Reply

Author Affiliations

Author Affiliations: Knowledge and Encounter Research Unit, Mayo Center for Translational Science Activities (Drs Montori, Shah, and Ting and Ms Mullan), Department of Health Sciences Research, Division of Health Care Policy and Research (Drs Montori and Shah), Divisions of Endocrinology, Diabetes, Metabolism, and Nutrition and Medicine (Dr Montori), and Division of Cardiovascular Diseases (Dr Ting), Mayo Clinic, Rochester, Minnesota.


Copyright 2010 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.2010

Arch Intern Med. 2010;170(5):496-497. doi:10.1001/archinternmed.2010.24

In reply

Crittenden and Shah raise concerns about “the real-world effectiveness of patient-centered decision aids in improving measurable outcomes and what those measures should be.” This is an important comment relevant to widespread implementation and applicability of patient-centered decision aids across different clinician, patient, and practice contexts. The Diabetes Medication Choice trial aimed to evaluate “efficacy” of a decision aid to improve patient knowledge, involvement in making a decision, and adherence and glycemic control in a single practice context.1 However, it was not designed to document real-world effectiveness across different practice contexts or how to normalize their use into routine usual care.2

First Page Preview View Large
First page PDF preview
First page PDF preview